These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 3686457

  • 1. Low serum testosterone as an indicator of metastatic bronchial carcinoma.
    Taggart DP, Gray C, Davidson KG, Faichney A.
    Thorax; 1987 Sep; 42(9):661-3. PubMed ID: 3686457
    [Abstract] [Full Text] [Related]

  • 2. Low serum testosterone as an indicator of metastatic bronchial carcinoma.
    Moore-Gillon J.
    Thorax; 1988 Feb; 43(2):159-60. PubMed ID: 3353892
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma.
    Concannon JP, Dalbow MH, Hodgson SE, Headings JJ, Markopoulos E, Mitchell J, Cushing WJ, Liebler GA.
    Cancer; 1978 Sep; 42(3 Suppl):1477-83. PubMed ID: 709518
    [No Abstract] [Full Text] [Related]

  • 4. [Chances in surgical treatment of bronchial carcinoma under palliative conditions].
    Liewald F, Förster R, Halter G, Zimmermann J.
    Zentralbl Chir; 2001 Mar; 126(3):217-22. PubMed ID: 11301888
    [Abstract] [Full Text] [Related]

  • 5. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P, Glagolicová A, Linhart M, Sebes A, Hencl P, Mĕricka O.
    Neoplasma; 1993 Mar; 40(5):301-3. PubMed ID: 8272159
    [Abstract] [Full Text] [Related]

  • 6. Bronchial sleeve resection with complete preservation of the lung for carcinoma.
    Ohta Y, Yachi T, Oda M, Sato H, Shimizu J, Watanabe Y, Watanabe G.
    Respiration; 2001 Mar; 68(5):528-32. PubMed ID: 11694818
    [Abstract] [Full Text] [Related]

  • 7. Serum copper, zinc, and iron in patients with malignant and benign pulmonary diseases.
    el-Ahmady O, el-Maraghy A, Ibrahim A, Ramzy S.
    Nutrition; 1995 Mar; 11(5 Suppl):498-501. PubMed ID: 8748208
    [Abstract] [Full Text] [Related]

  • 8. [Surgical experience of bronchogenic early squamous cell carcinoma detected by sputum cytology in lung cancer screening].
    Saito Y, Nagamoto N, Sagawa M, Takahashi S, Usuda K, Fujimura S, Nakada T, Imai T, Hashimoto K, Ohkuda K.
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):560-6. PubMed ID: 2373888
    [Abstract] [Full Text] [Related]

  • 9. Ectopic hormones in lung cancer patients at diagnosis and during therapy.
    Gropp C, Havemann K, Scheuer A.
    Cancer; 1980 Jul 15; 46(2):347-54. PubMed ID: 6248192
    [Abstract] [Full Text] [Related]

  • 10. Abnormal serum hormone levels in lung cancer.
    Recchione C, Galante E, Secreto G, Cavalleri A, Dati V.
    Tumori; 1983 Aug 31; 69(4):293-8. PubMed ID: 6312649
    [Abstract] [Full Text] [Related]

  • 11. [Preoperative status of serum proteins in lung surgery patients].
    Schulz T, Neef H.
    Zentralbl Chir; 1995 Aug 31; 120(9):677-81. PubMed ID: 7483867
    [Abstract] [Full Text] [Related]

  • 12. Circulating hormones in lung cancer.
    Behera D, Malik SK, Sharma BR, Dash RJ.
    Indian J Med Res; 1984 May 31; 79():636-40. PubMed ID: 6096269
    [No Abstract] [Full Text] [Related]

  • 13. [The behavior of trace elements in bronchial carcinoma].
    Dawczynski H, Bartel M, Wagner W.
    Z Exp Chir Transplant Kunstliche Organe; 1988 May 31; 21(6):344-7. PubMed ID: 3223012
    [Abstract] [Full Text] [Related]

  • 14. Serum vitamin 'A' in bronchogenic carcinoma.
    Jain NC, Gupta AP, Saksena HC.
    J Assoc Physicians India; 1984 Jun 31; 32(6):485-6. PubMed ID: 6511722
    [No Abstract] [Full Text] [Related]

  • 15. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA, Castillo S, Schultz PN, Khalil KG, Johnston DA.
    J Clin Endocrinol Metab; 1980 Aug 31; 51(2):237-41. PubMed ID: 6249833
    [Abstract] [Full Text] [Related]

  • 16. Serum hexosamine and its correlations with serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Kokkola K, Tani P.
    Scand J Respir Dis Suppl; 1972 Aug 31; 80():137-41. PubMed ID: 4510910
    [No Abstract] [Full Text] [Related]

  • 17. Clinical significance of tumor necrosis factor in patients with bronchogenic carcinoma and benign lung diseases: a comparative study.
    Rapellino M, Pecchio F, Aimo G, Priolo G, Baldi S, Ruffini E, Cianci R.
    Int J Biol Markers; 1992 Aug 31; 7(2):103-6. PubMed ID: 1634820
    [Abstract] [Full Text] [Related]

  • 18. [Bronchial biopsy, curative treatment for in situ cancers!].
    Breton JL, Ranfaing E, Clément F, Garnier G.
    Rev Mal Respir; 1994 Aug 31; 11(3):317. PubMed ID: 8042001
    [No Abstract] [Full Text] [Related]

  • 19. Perioperative behavior of prostaglandin E2 and 13,14-dihydro-15-keto-PGF2 alpha in serum of bronchial carcinoma patients.
    Fiedler L, Zahradnik HP, Schlegel G.
    Adv Prostaglandin Thromboxane Res; 1980 Aug 31; 6():585-6. PubMed ID: 7386293
    [No Abstract] [Full Text] [Related]

  • 20. Serum iron, copper, and iron-binding capacity in bronchogenic pulmonary carcinoma.
    Tani P, Kokkola K.
    Scand J Respir Dis Suppl; 1972 Aug 31; 80():121-8. PubMed ID: 4510909
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.